Evidence map›Paper›PMID 39475209›Full record

ArticleChemMedChem2025

Profiling Cysteine Proteases Activities in Neuroinflammatory Cells.

Laura Agost-Beltrán, Ania Canseco-Rodríguez, Tanja Schirmeister, Santiago Rodríguez, Ana María Sánchez-Pérez, Florenci V González

Abstract read
In one paragraph

Article in ChemMedChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laura Agost-BeltránDepartament de Química Inorgànica i Orgànica, Universitat Jaume I, Castelló de la Plana, 12071, Spain.ORCID https://orcid.org/0000-0002-6495-4677
Ania Canseco-RodríguezNeurobiotecnologia, Institute of advanced materials (INAM), Universitat Jaume I, Castelló de la Plana, 12071, Spain.
Tanja SchirmeisterInstitute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, Staudinger Weg 5, Mainz, D-55128, Germany.ORCID https://orcid.org/0000-0002-4587-5076
Santiago RodríguezDepartament de Química Inorgànica i Orgànica, Universitat Jaume I, Castelló de la Plana, 12071, Spain.ORCID https://orcid.org/0000-0003-3861-0990
Ana María Sánchez-PérezNeurobiotecnologia, Institute of advanced materials (INAM), Universitat Jaume I, Castelló de la Plana, 12071, Spain.ORCID https://orcid.org/0000-0002-5811-0005
Florenci V GonzálezDepartament de Química Inorgànica i Orgànica, Universitat Jaume I, Castelló de la Plana, 12071, Spain.

Funding

crowdfunding ("Biotecnología contra el Alzheimer")Generalitat Valenciana CIPROM/2021/079Universitat Jaume I UJI-B2021-21Universitat Jaume I UJI-B2021-71
6 · The paper itself

Abstract

A new activity-based probe (ABP) of cysteine proteases (FGA139) has been designed and synthesized. The design of the ABP has been done based upon the chemical structure of an irreversible inhibitor of cysteine proteases by attaching a bodipy fluorophore at the N-terminus of the peptide backbone. The synthetic route of the probe has a metathesis and a "click" reaction as key steps. Although some studies have been reported about the role played by cysteine proteases in neurodegenerative diseases, there are not definitive conclusions. The obtained ABP has been employed as a chemical tool to profile activities of cysteine proteases cathepsins B, L, and calpain in neurodegenerative cell models through confocal imaging. Colocalization of the probe to specific antibodies of the proteases and competitive experiments with non-fluorescent inhibitors confirm the specificity of the ABP. From a theranostic perspective, our findings strongly suggest that FGA139 exhibits a protective role in various cell lines against oxidative stress or pro-inflammatory toxicity and it effectively attenuates macrophage activation triggered by LPS.

Indexed as

Cysteine ProteasesCysteine Proteinase InhibitorsFluorescent DyesAnimalsBoron CompoundsDose-Response Relationship, DrugHumansLipopolysaccharidesMiceMolecular StructureStructure-Activity Relationship4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoron CompoundsCysteine ProteasesCysteine Proteinase InhibitorsFluorescent DyesLipopolysaccharidesActivity-based probesAlzheimer's diseaseCathepsinsCovalent inhibitors

Identifiers

PMID39475209
PMCPMC11793851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.